Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.

Scope of the Report:

North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.

The global Noninvasive Prenatal Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Noninvasive Prenatal Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Noninvasive Prenatal Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Noninvasive Prenatal Diagnostics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Natera

Illumina

BGI Diagnosis

Ariosa Diagnostics

Quest Diagnostics

Premaitha Health

NIPD Genetics

Labcorp

Ravgen

LifeCodexx

TrovaGene

Quest Diagnostics

Berry Genomics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Services

Instrument

Market Segment by Applications, can be divided into

Hospital

Personal

Other

Table of Contents

1 Noninvasive Prenatal Diagnostics Market Overview

1.1 Product Overview and Scope of Noninvasive Prenatal Diagnostics

1.2 Classification of Noninvasive Prenatal Diagnostics by Types

1.2.1 Global Noninvasive Prenatal Diagnostics Revenue Comparison by Types (2017-2023)

1.2.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Types in 2017

1.2.3 Services

1.2.4 Instrument

1.3 Global Noninvasive Prenatal Diagnostics Market by Application

1.3.1 Global Noninvasive Prenatal Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital

1.3.3 Personal

1.3.4 Other

1.4 Global Noninvasive Prenatal Diagnostics Market by Regions

1.4.1 Global Noninvasive Prenatal Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Noninvasive Prenatal Diagnostics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Noninvasive Prenatal Diagnostics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Noninvasive Prenatal Diagnostics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Noninvasive Prenatal Diagnostics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Noninvasive Prenatal Diagnostics Status and Prospect (2013-2023)

1.5 Global Market Size of Noninvasive Prenatal Diagnostics (2013-2023)

2 Manufacturers Profiles

2.1 Natera

2.1.1 Business Overview

2.1.2 Noninvasive Prenatal Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Natera Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Illumina

2.2.1 Business Overview

2.2.2 Noninvasive Prenatal Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Illumina Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.3 BGI Diagnosis

2.3.1 Business Overview

2.3.2 Noninvasive Prenatal Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ariosa Diagnostics

2.4.1 Business Overview

2.4.2 Noninvasive Prenatal Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Quest Diagnostics

2.5.1 Business Overview

2.5.2 Noninvasive Prenatal Diagnostics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Premaitha Health

2.6.1 Business Overview

2.6.2 Noninvasive Prenatal Diagnostics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.7 NIPD Genetics

2.7.1 Business Overview

2.7.2 Noninvasive Prenatal Diagnostics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Labcorp

2.8.1 Business Overview

2.8.2 Noninvasive Prenatal Diagnostics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Labcorp Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ravgen

2.9.1 Business Overview

2.9.2 Noninvasive Prenatal Diagnostics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ravgen Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.10 LifeCodexx

2.10.1 Business Overview

2.10.2 Noninvasive Prenatal Diagnostics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.11 TrovaGene

2.11.1 Business Overview

2.11.2 Noninvasive Prenatal Diagnostics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 TrovaGene Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.12 Quest Diagnostics

2.12.1 Business Overview

2.12.2 Noninvasive Prenatal Diagnostics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.13 Berry Genomics

2.13.1 Business Overview

2.13.2 Noninvasive Prenatal Diagnostics Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Noninvasive Prenatal Diagnostics Market Competition, by Players

3.1 Global Noninvasive Prenatal Diagnostics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Noninvasive Prenatal Diagnostics Players Market Share

3.2.2 Top 10 Noninvasive Prenatal Diagnostics Players Market Share

3.3 Market Competition Trend

4 Global Noninvasive Prenatal Diagnostics Market Size by Regions

4.1 Global Noninvasive Prenatal Diagnostics Revenue and Market Share by Regions

4.2 North America Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

4.3 Europe Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

4.5 South America Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

5 North America Noninvasive Prenatal Diagnostics Revenue by Countries

5.1 North America Noninvasive Prenatal Diagnostics Revenue by Countries (2013-2018)

5.2 USA Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

5.3 Canada Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

5.4 Mexico Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

6 Europe Noninvasive Prenatal Diagnostics Revenue by Countries

6.1 Europe Noninvasive Prenatal Diagnostics Revenue by Countries (2013-2018)

6.2 Germany Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

6.3 UK Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

6.4 France Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

6.5 Russia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

6.6 Italy Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Countries

7.1 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Countries (2013-2018)

7.2 China Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

7.3 Japan Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

7.4 Korea Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

7.5 India Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

8 South America Noninvasive Prenatal Diagnostics Revenue by Countries

8.1 South America Noninvasive Prenatal Diagnostics Revenue by Countries (2013-2018)

8.2 Brazil Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

8.3 Argentina Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

8.4 Colombia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Noninvasive Prenatal Diagnostics by Countries

9.1 Middle East and Africa Noninvasive Prenatal Diagnostics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

9.3 UAE Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

9.4 Egypt Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

9.6 South Africa Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2013-2018)

10 Global Noninvasive Prenatal Diagnostics Market Segment by Type

10.1 Global Noninvasive Prenatal Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Type (2018-2023)

10.3 Services Revenue Growth Rate (2013-2023)

10.4 Instrument Revenue Growth Rate (2013-2023)

11 Global Noninvasive Prenatal Diagnostics Market Segment by Application

11.1 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Application (2013-2018)

11.2 Noninvasive Prenatal Diagnostics Market Forecast by Application (2018-2023)

11.3 Hospital Revenue Growth (2013-2018)

11.4 Personal Revenue Growth (2013-2018)

11.5 Other Revenue Growth (2013-2018)

12 Global Noninvasive Prenatal Diagnostics Market Size Forecast (2018-2023)

12.1 Global Noninvasive Prenatal Diagnostics Market Size Forecast (2018-2023)

12.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Regions (2018-2023)

12.3 North America Noninvasive Prenatal Diagnostics Revenue Market Forecast (2018-2023)

12.4 Europe Noninvasive Prenatal Diagnostics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue Market Forecast (2018-2023)

12.6 South America Noninvasive Prenatal Diagnostics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Noninvasive Prenatal Diagnostics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Noninvasive Prenatal Diagnostics Picture

Table Product Specifications of Noninvasive Prenatal Diagnostics

Table Global Noninvasive Prenatal Diagnostics and Revenue (